Manufacturer record
KRAS Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by KRAS Pharmaceuticals Pvt. Ltd (Bihar) were declared Not of Standard Quality between February 2022 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 25T19052, Diclofenac Gastro-resistant Tablets I.P. 50 mg (exp Jan 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to IP with respect to test for Dissolution in Buffer Stage. Listed in the December 2025 alert.
Records by type
3 records linked to KRAS Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Gastro-resistant Tablets I.P. 50 mg | Batch 25T19052Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to IP with respect to test for Dissolution in Buffer Stage.Dissolution | CDL, KolkataCDSCO lab | Dec 2025 |
| OMZOLE (Omeprazole Gastro Resistant Capsules IP) | Batch 22C06001Mfg May 2022 · Exp Apr 2024 | Dissolution in Acid stageDissolution | RDTL GuwahatiState lab | Oct 2022 |
| Paracetamol Tablets I.P. 500 mg | Batch 19T20003Mfg Jul 2019 · Exp Jun 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.